Physician

Ludmila Katherine Martin, MD

According to 2025 Medicare claims, Ludmila Martin, MD (NPI: 1568653509) practices medical oncology in the Tacoma-Lakewood, WA market, with the plurality of this provider's patient population coming from Pierce, WA. This provider's primary affiliated billing organization is NORTHWEST MEDICAL SPECIALTIES PLLC (NPI: 1548261308; TIN: 911867315) and primary practice location at 98373-1659. Martin is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Martin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 546 traditional Medicare patients, billed 214,780 HCPCS/CPT codes, and received $2,753,585 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,141 prescription claims across 226 beneficiaries totaling $2,093,412 in drug costs, led by Revlimid (Lenalidomide). DME data shows 21 claims. Open Payments data shows 36 records totaling $25,917. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,302,879 to $2,753,585. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $385,972 to $2,093,412. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.1M2015 Medicare payment: $1,302,879 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,650,506 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,560,107 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,415,498 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,433,711 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,727,343 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,681,219 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,773,199 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,076,312 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,753,585 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015488113,204$1,302,879
2016650213,193$1,650,506
2017905346,303$2,560,107
2018819341,285$2,415,498
2019727279,922$2,433,711
2020693253,692$2,727,343
2021634266,751$2,681,219
2022534249,038$2,773,199
2023584248,815$3,076,312
2024546214,780$2,753,585

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.5M2015 Drug cost: $385,972 (USD; Tot_Drug_Cst)2016 Drug cost: $747,575 (USD; Tot_Drug_Cst)2017 Drug cost: $573,374 (USD; Tot_Drug_Cst)2018 Drug cost: $1,049,668 (USD; Tot_Drug_Cst)2019 Drug cost: $1,577,189 (USD; Tot_Drug_Cst)2020 Drug cost: $1,844,128 (USD; Tot_Drug_Cst)2021 Drug cost: $2,208,807 (USD; Tot_Drug_Cst)2022 Drug cost: $2,472,495 (USD; Tot_Drug_Cst)2023 Drug cost: $2,188,261 (USD; Tot_Drug_Cst)2024 Drug cost: $2,093,412 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151361,060$385,972
20161641,380$747,575
20171771,484$573,374
20182051,790$1,049,668
20192001,806$1,577,189
20202182,204$1,844,128
20212141,863$2,208,807
20222021,575$2,472,495
20232091,917$2,188,261
20242262,141$2,093,412

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$11K$21K2015 Medicare payment: $13,800 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $11,383 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $4,207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,868 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $7,353 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $4,102 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $21,136 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $395 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201569281$13,800
201682296$11,383
2017N/R111$4,207
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R26$2,868
202136115$7,353
202226106$4,102
202330114$21,136
2024N/R21$395

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more152414$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's139301$13
80053Blood test, comprehensive group of blood chemicals204779$10
36415Insertion of needle into vein for collection of blood sample198751$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count209825$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide18504$334,726
XtandiEnzalutamide16480$216,314
LenalidomideLenalidomide12336$157,606
CalquenceAcalabrutinib Maleate14420$139,464
XermeloTelotristat Etiprate12336$114,184

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R21$395

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$2,467Ipsen Biopharmaceuticals, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.4$23,450Merck Sharp & Dohme LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ludmila Katherine Martin, MD?

Tedicare shows public-source Medicare data for Ludmila Katherine Martin, MD (NPI 1568653509), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ludmila Katherine Martin, MD have ACO affiliation data?

Ludmila Katherine Martin, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Ludmila Katherine Martin, MD?

Ludmila Katherine Martin, MD is linked to NORTHWEST MEDICAL SPECIALTIES PLLC (billing NPI 1548261308) in the available physician profile data.

Does Ludmila Katherine Martin, MD have Open Payments data?

Ludmila Katherine Martin, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.